DJIA 16,039.85 -165.12 -1.02%
NASDAQ 4,289.56 -73.59 -1.69%
S&P 500 1,855.40 -24.65 -1.31%
market minute promo

ATOSSA GENETICS INC COM (NASDAQ: ATOS)

0.24 -0.02 (-7.69%)

Quote as of


company name or ticker

Recent Quotes

ATOS $0.24 -7.69%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.26
Previous Close $0.26
Daily Range $0.23 - $0.27
52-Week Range $0.14 - $2.65
Market Cap $7.3M
P/E Ratio -0.41
Dividend (Yield) $0.00 (0.0%)
Volume 161,197
Average Daily Volume 259,772
Current FY EPS -$0.53

Sector

Industry

ATOSSA GENETICS INC COM (ATOS) Description

ATOSSA GENETICS INC COM Website: http://www.atossagenetics.com/

News & Commentary Rss Feed

Ambitious Atossa Genetics Going After Two Breast Cancer Blockbusters

Atossa Genetics' (ATOS) CEO Steven Quay on Q3 2015 Results - Earnings Call Transcript

Atossa (ATOS) Stock Up, FDA Accepts Fulvestrant Investigational Drug Application

Atossa Genetics Receives Approval to Begin Clinical Study in Israel

Premarket Biotech Digest: Hep C Vaccine, Big Month For Arrowhead, Gilead's Positive Phase III For F/

Premarket Biotech Digest: Hep C Vaccine, Big Month For Arrowhead, Gilead's Positive Phase III For F/TAF Combo

Premarket Biotech Digest: SeekingAlpha Biotech Idea, Gilead Sales Updates, Sanofi Diabetes Collabora

Premarket Biotech Digest: SeekingAlpha Biotech Idea, Gilead Sales Updates, Sanofi Diabetes Collaboration

Atossa Genetics' (ATOS) Steven Quay on Q2 2015 Results - Earnings Call Transcript

Atossa Genetics and AAIPharma / Cambridge Major Laboratories Announce Manufacturing Agreement For At

Atossa Genetics and AAIPharma / Cambridge Major Laboratories Announce Manufacturing Agreement For Atossa's Lead Drug Candidate Afimoxifene Gel

Atossa Genetics (ATOS) Stock Gains After Receiving Breast Cancer Detection Patent

Atossa Genetics' (ATOS) CEO Steven Quay on Q1 2015 Results - Earnings Call Transcript

See More ATOS News...